accountMay 12 (Bloomberg) -- Pfizer Inc. said it set aside $772 million to resolve claims that its Prempro menopause drug causes breast cancer and has settled a third of the pending cases filed over the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Sets Aside $772 Million to Resolve Menopause-Drug Cases
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account